DermTech Obtains $5,600,000 Series B Funding Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    11099 N. Torrey Pines Road La Jolla, CA 92037
  • Company Description
    DermTech develops and commercializes qPCR assays for skin samples collected non-invasively using adhesive tape biopsy methods. The Company’s assays can analyze multiple gene targets to assess their level of RNA expression. The Company anticipates providing these assays through a CLIA certified laboratory located in San Diego.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds from the financing will be used to fund further development, complete commercial validation of assays, and achieve the necessary laboratory accreditation.
  • M&A Terms
  • Venture Investor
    Jacobs Investment
  • Venture Investor

Trending on Xconomy